1.
Atheroprotective roles of smooth muscle cell phenotypic modulation and the TCF21 disease gene as revealed by single-cell analysis
by Wirka, Robert C
Nature medicine, 2019-08, Vol.25 (8), p.1280-1289
2.
Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints t...
by Kobayashi, Tohru, Dr
The Lancet (British edition), 2012, Vol.379 (9826), p.1613-1620
3.
Associations between C-reactive protein, coronary artery calcium, and cardiovascular events: implications for the JUPITER population from MESA, a population-based cohort study
by Blaha, Michael J, Dr
The Lancet (British edition), 2011, Vol.378 (9792), p.684-692
4.
Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial
by Fayad, Zahi A, Prof
The Lancet (British edition), 2011, Vol.378 (9802), p.1547-1559
5.
Cardiovascular effects of marine omega-3 fatty acids
by Saravanan, Palaniappan, Dr
The Lancet (British edition), 2010, Vol.376 (9740), p.540-550
6.
Intravenous immunoglobulin plus corticosteroid to prevent coronary artery abnormalities in Kawasaki disease: a meta-analysis
by Chen, Shaojie
Heart, 2013-01, Vol.99 (2), p.76-82
7.
Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development
by Wilensky, Robert L
Nature medicine, 2008-10, Vol.14 (10), p.1059-1066
8.
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial
by Shepherd, James
The Lancet (British edition), 2002-11-23, Vol.360 (9346), p.1623-1630
9.
The Kronos Early Estrogen Prevention Study (KEEPS): what have we learned?
by Miller, Virginia M
Menopause (New York, N.Y.), 2019-09, Vol.26 (9), p.1071-1084
10.
From Vulnerable Plaque to Vulnerable Patient—Part III: Executive Summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force Report
by Naghavi, Morteza
The American journal of cardiology, 2006, Vol.98 (2), p.2-15
11.
Lupus Atherosclerosis Prevention Study (LAPS)
by Petri, M A
Annals of the rheumatic diseases, 2011-05, Vol.70 (5), p.760-765
12.
Factors of Health in the Protection against Death and Cardiovascular Disease among Adults with Subclinical Atherosclerosis
by Rifai, Mahmoud Al Mahmoud Al
The American heart journal, 2017-11-11, Vol.198, p.180-188
13.
Assessment of the clinical effects of cholesteryl ester transfer protein inhibition with evacetrapib in patients at high-risk for vascular outcomes: Rationale and design of the ACC...
by Nicholls, Stephen J., MBBS, PhD
The American heart journal, 2015, Vol.170 (6), p.1061-1069
14.
Longitudinal cohort study on the effectiveness of lipid apheresis treatment to reduce high lipoprotein(a) levels and prevent major adverse coronary events
by Jaeger, Beate R
Nature clinical practice cardiovascular medicine, 2009-03, Vol.6 (3), p.229-239
15.
Timing hypothesis for postmenopausal hormone therapy: its origin, current status, and future
by Clarkson, Thomas B.
Menopause (New York, N.Y.), 2013-03, Vol.20 (3), p.342-353
16.
Antiplatelet therapy for secondary prevention of coronary artery disease
by Pilgrim, Thomas
Heart, 2014-11, Vol.100 (22), p.1750-1756
17.
Associations between antiretroviral use and subclinical coronary atherosclerosis
by Thomas, Guajira P
AIDS (London), 2016-10-23, Vol.30 (16), p.2477-2486
18.
Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial: Design and Methods
by Buse, John B., MD, PhD
The American journal of cardiology, 2007, Vol.99 (12), p.S21-S33
19.
A protective smooth muscle cell transition in atherosclerosis
by Pan, Huize
Nature medicine, 2019-08, Vol.25 (8), p.1194-1195
20.
Effect of an Indo-Mediterranean diet on progression of coronary artery disease in high risk patients (Indo-Mediterranean Diet Heart Study): a randomised single-blind trial
by Singh, Ram B
The Lancet (British edition), 2002-11-09, Vol.360 (9344), p.1455-1461
